Participants were then randomised to receive either a continuation of tirzepatide or placebo for a further 52 weeks
Mental health considerations when stopping GLP-1 medications The psychological dimension of getting off GLP-1 medications rarely gets the attention it deserves
[DOI] [PMC free article] [PubMed] [Google Scholar] 44.Moianu A., Mnescu I.B., erban G., Brcuean L., Ion V., Blaa R., et al
It is known for impressive weight loss outcomes, with participants losing up to 20.9% of their body weight
En revanche, en cas de consommation frquente ou fortes doses, et si vos rserves sont basses, ce compos toxique peut endommager les cellules hpatiques et entraner des lsions du foie
IGF-1 is a growth and survival signal, so persistently high exposure raises a theoretical concern about feeding an existing malignancy